Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 26 | 2023 | 2119 | 2.020 |
Why?
|
| Brain | 24 | 2023 | 1648 | 1.900 |
Why?
|
| Transcriptome | 9 | 2023 | 91 | 1.680 |
Why?
|
| Proteomics | 6 | 2022 | 88 | 1.120 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 143 | 1.080 |
Why?
|
| Algorithms | 4 | 2023 | 352 | 1.060 |
Why?
|
| Cognitive Dysfunction | 12 | 2022 | 1069 | 0.980 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 28 | 0.940 |
Why?
|
| Proteome | 3 | 2022 | 41 | 0.930 |
Why?
|
| RNA, Messenger | 3 | 2022 | 317 | 0.900 |
Why?
|
| Cluster Analysis | 2 | 2023 | 47 | 0.700 |
Why?
|
| Nerve Net | 2 | 2019 | 40 | 0.660 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 290 | 0.650 |
Why?
|
| Dementia | 2 | 2022 | 567 | 0.620 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2023 | 369 | 0.550 |
Why?
|
| Genome-Wide Association Study | 6 | 2023 | 276 | 0.510 |
Why?
|
| Models, Neurological | 1 | 2016 | 27 | 0.510 |
Why?
|
| Humans | 41 | 2023 | 27307 | 0.470 |
Why?
|
| Models, Theoretical | 1 | 2015 | 84 | 0.470 |
Why?
|
| Aged, 80 and over | 17 | 2022 | 4841 | 0.460 |
Why?
|
| Aging | 8 | 2023 | 1555 | 0.460 |
Why?
|
| Foot Deformities | 1 | 2014 | 1 | 0.460 |
Why?
|
| Myofascial Pain Syndromes | 1 | 2014 | 1 | 0.460 |
Why?
|
| Pyridoxal Phosphate | 1 | 2014 | 1 | 0.460 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 44 | 0.450 |
Why?
|
| DNA Methylation | 5 | 2022 | 165 | 0.450 |
Why?
|
| Gene Expression | 5 | 2023 | 201 | 0.440 |
Why?
|
| Microglia | 5 | 2023 | 145 | 0.400 |
Why?
|
| Genome, Human | 3 | 2018 | 45 | 0.400 |
Why?
|
| Cognition | 6 | 2021 | 1339 | 0.390 |
Why?
|
| Aged | 19 | 2023 | 9120 | 0.390 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 154 | 0.360 |
Why?
|
| Genotype | 4 | 2019 | 344 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 26 | 0.350 |
Why?
|
| Male | 22 | 2022 | 14887 | 0.340 |
Why?
|
| Hormones | 1 | 2010 | 15 | 0.330 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 99 | 0.330 |
Why?
|
| Female | 21 | 2022 | 15334 | 0.330 |
Why?
|
| Amyloid beta-Peptides | 6 | 2021 | 325 | 0.310 |
Why?
|
| Autopsy | 6 | 2019 | 343 | 0.310 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 86 | 0.290 |
Why?
|
| Cohort Studies | 8 | 2020 | 1903 | 0.280 |
Why?
|
| Apolipoprotein E4 | 3 | 2019 | 265 | 0.280 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 54 | 0.260 |
Why?
|
| Motor Activity | 2 | 2019 | 321 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 43 | 0.240 |
Why?
|
| Phenotype | 4 | 2023 | 313 | 0.230 |
Why?
|
| Benchmarking | 1 | 2023 | 34 | 0.210 |
Why?
|
| Apolipoproteins E | 3 | 2020 | 253 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 136 | 0.200 |
Why?
|
| Multifactorial Inheritance | 2 | 2019 | 23 | 0.200 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2019 | 18 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 155 | 0.190 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 84 | 0.190 |
Why?
|
| Mutation | 2 | 2014 | 353 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 17 | 0.190 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 34 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.190 |
Why?
|
| Astrocytes | 2 | 2020 | 147 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 112 | 0.180 |
Why?
|
| Neurons | 4 | 2021 | 340 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 18 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2020 | 171 | 0.180 |
Why?
|
| Models, Genetic | 3 | 2020 | 34 | 0.180 |
Why?
|
| Haplotypes | 2 | 2020 | 56 | 0.180 |
Why?
|
| Neurofibrillary Tangles | 2 | 2019 | 195 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 67 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 101 | 0.170 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 6 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 97 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 39 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 7 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 204 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2019 | 14 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Histones | 1 | 2019 | 36 | 0.160 |
Why?
|
| Neuroimaging | 1 | 2019 | 129 | 0.150 |
Why?
|
| Independent Living | 2 | 2019 | 321 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 22 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Frontal Lobe | 1 | 2018 | 82 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 114 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1108 | 0.140 |
Why?
|
| Risk Factors | 6 | 2019 | 2335 | 0.140 |
Why?
|
| Brain Infarction | 1 | 2017 | 76 | 0.140 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 16 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 20 | 0.130 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 275 | 0.130 |
Why?
|
| Postural Balance | 1 | 2018 | 116 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 132 | 0.130 |
Why?
|
| Lewy Bodies | 4 | 2019 | 193 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 287 | 0.130 |
Why?
|
| Schiff Bases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 1 | 0.110 |
Why?
|
| tau Proteins | 3 | 2021 | 235 | 0.110 |
Why?
|
| Exercise | 1 | 2019 | 452 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 16 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 13 | 0.110 |
Why?
|
| Mitochondria | 1 | 2014 | 66 | 0.110 |
Why?
|
| Fibromyalgia | 1 | 2014 | 30 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 1198 | 0.110 |
Why?
|
| Gait | 1 | 2018 | 413 | 0.110 |
Why?
|
| Behavior | 1 | 2013 | 25 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2013 | 28 | 0.100 |
Why?
|
| Amygdala | 2 | 2010 | 42 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 66 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2013 | 30 | 0.100 |
Why?
|
| Animals | 5 | 2020 | 3681 | 0.100 |
Why?
|
| Linear Models | 3 | 2018 | 247 | 0.090 |
Why?
|
| Mice | 4 | 2020 | 1449 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1380 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 45 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 70 | 0.080 |
Why?
|
| Alleles | 2 | 2021 | 208 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 375 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 270 | 0.080 |
Why?
|
| Sclerosis | 2 | 2019 | 69 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2018 | 51 | 0.070 |
Why?
|
| Biomarkers | 2 | 2020 | 561 | 0.060 |
Why?
|
| Hippocampus | 2 | 2019 | 275 | 0.060 |
Why?
|
| Species Specificity | 2 | 2020 | 39 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 42 | 0.050 |
Why?
|
| Molecular Biology | 1 | 2023 | 11 | 0.050 |
Why?
|
| Meninges | 1 | 2023 | 7 | 0.050 |
Why?
|
| Base Sequence | 1 | 2023 | 108 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 102 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 95 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 606 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 116 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 41 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 5 | 0.040 |
Why?
|
| Computational Biology | 1 | 2020 | 21 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 43 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 23 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 50 | 0.040 |
Why?
|
| Lysosomes | 1 | 2020 | 26 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 675 | 0.040 |
Why?
|
| Pharmacology | 1 | 2019 | 1 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 124 | 0.040 |
Why?
|
| Acetylation | 1 | 2019 | 16 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 225 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 118 | 0.040 |
Why?
|
| Metabolomics | 1 | 2018 | 15 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 146 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 14 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 15 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 589 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 79 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 38 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 116 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 9068 | 0.040 |
Why?
|
| Heterozygote | 1 | 2018 | 102 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 9 | 0.040 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 13 | 0.040 |
Why?
|
| Substantia Nigra | 1 | 2019 | 120 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 43 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 89 | 0.030 |
Why?
|
| Epigenomics | 1 | 2017 | 21 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 33 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 398 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 9 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 95 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 107 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 90 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 209 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 216 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 352 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 953 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 7945 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 903 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 258 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 55 | 0.030 |
Why?
|
| Amyloid | 1 | 2015 | 57 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 33 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 50 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 148 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 469 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 66 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1807 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 986 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 671 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2078 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 14 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 103 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 97 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 425 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2009 | 235 | 0.020 |
Why?
|